A blinded, randomized, placebo‐controlled trial of the safety of lokivetmab ( ZTS ‐00103289), a caninized anti‐canine IL ‐31 monoclonal antibody in client‐owned dogs with atopic dermatitis-Reference-Cited by-同舟云学术

A blinded, randomized, placebo‐controlled trial of the safety of lokivetmab ( ZTS ‐00103289), a caninized anti‐canine IL ‐31 monoclonal antibody in client‐owned dogs with atopic dermatitis

Published:2016-09-19 Issue:6 Volume:27 Page:505
ISSN:0959-4493
Container-title:Veterinary Dermatology
language:en
Short-container-title:Vet Dermatol

Author:

Michels Gina M.¹,Walsh Kelly F.¹,Kryda Kristina A.¹,Mahabir Sean P.¹,Walters Rodney R.²,Hoevers Jacquelien D.¹,Martinon Olivier M.²

Affiliation:

1. Global Development and Operations Zoetis Inc.333 Portage Street Kalamazoo MI 49007 USA

2. Global Therapeutics Research Zoetis Inc. 333 Portage Street Kalamazoo MI 49007 USA

Funder

Zoetis Inc

Publisher

Wiley

Subject

General Veterinary

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/vde.12364

Reference10 articles.

1. A blinded, randomized, placebo‐controlled dose determination trial of lokivetmab (ZTS‐00103289), a caninized anti‐canine IL‐31 monoclonal antibody, in client‐owned dogs with atopic dermatitis;Michels GM;Vet Dermatol

2. IMGT/3Dstructure-DB and IMGT/DomainGapAlign: a database and a tool for immunoglobulins or antibodies, T cell receptors, MHC, IgSF and MhcSF

3. VICH International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products VICH GL9 (GCP) 2000. Available at:http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500004343.pdfAccessed June 23 2016.

4. Elimination mechanisms of therapeutic monoclonal antibodies

5. Mechanisms of Monoclonal Antibody–Drug Interactions

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A különböző immunológiai alapú terápiák alkalmazása a daganatok elleni küzdelemben : Irodalmi összefoglaló;Magyar Állatorvosok Lapja;2024

2. Characterisation of the pruritus responses and pruritic behaviours in an interleukin 31‐induced canine model of pruritus;Veterinary Dermatology;2023-12-27

3. A prospective, randomized, double-blind, placebo-controlled multisite, parallel-group field study in dogs with osteoarthritis conducted in the United States of America evaluating bedinvetmab, a canine anti-nerve growth factor monoclonal antibody;Veterinary Anaesthesia and Analgesia;2023-09

4. Non-controlled, open-label trial to assess clinical and immunological parameters in atopic dogs feeding monoprotein grain free diet versus a standard grain diet;Veterinary Quarterly;2023-08-11

5. Evaluation of the clinical efficiencyof lokivetmab in client privately ownedatopic dogs – multicenter study;Polish Journal of Veterinary Sciences;2023-07-26